Skip to Main content Skip to Navigation
Journal articles

Lycopene bioavailability is associated with a combination of genetic variants

Abstract : The intake of tomatoes and tomato products, which constitute the main dietary source of the red pigment Lycopene (LYC), has been associated with a reduced risk of prostate cancer and cardiovascular disease, suggesting a protective role of this carotenoid. However, LYC bioavailability displays high interindividual variability. This variability may lead to varying biological effects following LYC consumption. Based on recent results obtained with two other carotenoids, we assumed that this variability was due, at least in part, to several single nucleotide polymorphisms (SNPs) in genes involved in LYC and lipid metabolism. Thus, we aimed at identifying a combination of SNPs significantly associated with the variability in LYC bioavailability. In a postprandial study, 33 healthy male volunteers consumed a test meal containing 100 g tomato puree, which provided 9.7 mg all-trans LYC. LYC concentrations were measured in plasma chylomicrons (CM) isolated at regular time intervals over 8 h postprandially. For the study 1885 SNPs in 49 candidate genes, i.e., genes assumed to play a role in LYC bioavailability, were selected. Multivariate statistical analysis (partial least squares regression) was used to identify and validate the combination of SNPs most closely associated with postprandial CM LYC response. The postprandial CM LYC response to the meal was notably variable with a CV of 70%. A significant (P.-0.037) and validated partial least squares regression model, which included 28 SNPs in 16 genes, explained 72% of the variance in the postprandial CM LYC response. The postprandial CM LYC response was also positively correlated to fasting plasma LYC concentrations (r=0.37, P< 0.05). The ability to respond to LYC is explained, at least partly, by a combination of 28 SNPs in 16 genes. Interindividual variability in bioavailability apparently affects the long-term blood LYC status, which could ultimately modulate the biological response following LYC supplementation.
Document type :
Journal articles
Complete list of metadatas

https://www.hal.inserm.fr/inserm-01478367
Contributor : Patrick Borel <>
Submitted on : Tuesday, February 28, 2017 - 10:25:49 AM
Last modification on : Thursday, May 28, 2020 - 8:14:06 PM

Identifiers

Collections

Citation

Patrick Borel, Charles Desmarchelier, Marion Nowicki, Romain Bott. Lycopene bioavailability is associated with a combination of genetic variants. Free Radical Biology and Medicine, Elsevier, 2015, 83, pp.238 - 244. ⟨10.1016/j.freeradbiomed.2015.02.033⟩. ⟨inserm-01478367⟩

Share

Metrics

Record views

173